Want to join the conversation?
$CTLT's 4Q16 revenue from Softgel Technologies segment rose 1% as reported vs. 4Q15. Drug Delivery Solutions revenue rose 9% as reported driven by increased volumes related to fee-for-service development work and analytical testing in the U.S. 4Q16 Clinical Supply Services revenue rose 1% as reported vs. 4Q15.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?